NCT02803229View on ClinicalTrials.gov

Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Cannabis Use DisorderAttention-deficit/Hyperactivity Disorder
Interventions
DRUG

Adderall-XR

DRUG

Matched placebo

matched placebo provided for placebo arm

Trial Locations (1)

10032

New York Psychiatric Institute, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT02803229 - Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder | Biotech Hunter | Biotech Hunter